PDS Biotechnology’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

PDS Biotechnology engaged in developing immunotherapies for cancer. Read more

Frank K. Bedu-Addo's photo - President & CEO of PDS Biotechnology

President & CEO

Frank K. Bedu-Addo

CEO Approval Rating

69/100

Founded:

2005

Status:

PublicNASDAQPDSB

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Flexus Biosciences is one of PDS Biotechnology's top rivals. Flexus Biosciences's headquarters is in San Carlos, California, and was founded in 2013. Like PDS Biotechnology, Flexus Biosciences also competes in the Biotechnology industry. Flexus Biosciences generates ∞% of PDS Biotechnology's revenue.

TVAX has been one of PDS Biotechnology's top competitors. TVAX was founded in 2004 in Olathe, Kansas. Like PDS Biotechnology, TVAX also operates in the Biotechnology field. TVAX generates $6.3M more revenue than PDS Biotechnology.

Puma Biotechnology is one of PDS Biotechnology's top competitors. Puma Biotechnology was founded in Los Angeles, California} in 2010. Like PDS Biotechnology, Puma Biotechnology also competes in the Biotechnology sector. Compared to PDS Biotechnology, Puma Biotechnology generates $180.4M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Juno a competitor of PDS Biotechnology?

Quarterly and Annual Revenue

Coming soon for PDS Biotechnology!

Annual Revenue

Acquisitions

No recent acquisitions found related to PDS Biotechnology

PDS Biotechnology Funding History

$0$2M

Since PDS Biotechnology was founded in 2005, it has participated in 3 rounds of funding. In total PDS Biotechnology has raised $2.0M. PDS Biotechnology's last funding round was on Aug 2016 for a total of $1.1M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Aug 2016
$1.1M
-
Debt
Jul 2016
$902.5K
-
Equity
Dec 2014
--

Total Funding: $2M

Since PDS Biotechnology was founded in 2005, it has participated in 3 rounds of funding. In total PDS Biotechnology has raised $2.0M. PDS Biotechnology's last funding round was on Aug 2016 for a total of $1.1M

Investments

No recent investments found related to PDS Biotechnology

PDS Biotechnology News

August 13, 2020BioSpace

PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotechnology" or the "Company"), a clinical-stage... See more »
July 13, 2020MarketScreener

PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune-Based Universal Influenza Vaccine

(marketscreener.com) FLORHAM PARK, N.J., July 14, 2020 -- PDS Biotechnology Corporation , a clinical-... See more »
July 3, 2020The Markets Daily

PDS Biotechnology Corporation (NASDAQ:PDSB) Expected to Announce Earnings of -$0.26 Per Share

Wall Street brokerages expect PDS Biotechnology Corporation (NASDAQ:PDSB) to post earnings per share ... See more »
June 18, 2020Pharamceutical Technology

PDS Biotech and Farmacore partner to develop Covid-19 vaccine

US-based immunotherapy company PDS Biotechnology has partnered with Brazilian biotechnology firm Farm... See more »
June 17, 2020firstwordpharma

PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine

FLORHAM PARK, N.J., June 17, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a... See more »
June 6, 2020Zolmax News

PDS Biotechnology (NASDAQ:PDSB) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research downgraded shares of PDS Biotechnology (NASDAQ:PDSB) from a buy rating to a... See more »
June 3, 2020MarketScreener

PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Cancer

(marketscreener.com) FLORHAM PARK, N.J., June 04, 2020 -- PDS Biotechnology Corporation , a clinical-... See more »

PDS Biotechnology Press Releases

June 15, 2020centralcharts

PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 Led by the National Cancer Institute

FLORHAM PARK, N.J., June 15, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a... See more »
April 16, 2020LD Micro

PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial

Read this press release and other recent news about PDS Biotechnology Corporation (PDSB) at ldmicro.c... See more »
February 16, 2020Network Newswire

PDSB) Starts Presentation at NobleCon16 - NetworkNewsWire

PDS Biotechnology (NASDAQ: PDSB) is developing multiple therapies based on the Versamune® platform, w... See more »
December 11, 2019centralcharts

PDS Biotechnology Announces Principal Investigator and Independent Data Monitoring Committee for its Phase 2 Clinical Collaboration with Merck

PRINCETON, N.J., Dec. 11, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a cl... See more »
December 11, 2019StreetInsider

PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors

PRINCETON, N.J., Dec. 11, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a cl... See more »
October 22, 2019centralcharts

PDS Biotechnology Completes Manufacturing of Clinical Batches of PDS0101

PRINCETON, N.J., Oct. 22, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a cl... See more »
September 3, 2019GlobeNewswire

PDS Biotechnology to Present at the 21st Annual H.C. Wainwright Global Investment Conference

BERKELEY HEIGHTS, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation ("PDS Biotec... See more »

Headquarters

675 US Highway One

North Brunswick, New Jersey08902

732-640-0145

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

PDS Biotechnology engaged in developing immunotherapies for cancer. PDS Biotechnology was founded in 2005. PDS Biotechnology's headquarters is located in North Brunswick, New Jersey, USA 08902. It has raised 2.0M in 3 rounds. The latest round was in A...

CEO

PDS Biotechnology's President & CEO, Frank K. Bedu-Addo, currently has an approval rating of 69%. PDS Biotechnology's primary competitors are Flexus Biosciences, TVAX & Puma Biotechnology.

Website

pdsbiotech.com

Frequently Asked Questions about PDS Biotechnology

  1. When was PDS Biotechnology founded?

    PDS Biotechnology was founded in 2005
  2. Who is PDS Biotechnology's CEO?

    PDS Biotechnology's CEO is Frank K. Bedu-Addo
  3. How much revenue does PDS Biotechnology generate?

    PDS Biotechnology generates $ < 1M in revenue
  4. How much funding does PDS Biotechnology have?

    PDS Biotechnology has historically raised $2M in funding
  1. Where is PDS Biotechnology's headquarters?

    PDS Biotechnology's headquarters is in North Brunswick New Jersey, USA
  2. How many employees does PDS Biotechnology have?

    PDS Biotechnology has 488 employees
  3. What sector does PDS Biotechnology operate in?

    PDS Biotechnology is in Biotechnology
  4. Who are PDS Biotechnology's competitors?

    PDS Biotechnology's top competitors are Flexus Biosciences, TVAX, Puma Biotechnology